GSK PLC closed 20.35% short of its 52-week high of £18.24, which the company achieved on May 16th.

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

Martin has since learned that shingles is caused by the reactivation of the varicella zoster virus, the same virus that ...

GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...

Veterinarians on Prince Edward Island who have been monitoring the spread of avian influenza for years are encouraged by the ...

Friday’s weak performance by US equities means London’s FTSE 100 index is set for a subdued start to the new week. The FTSE ...

(HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), ...

Belgium plans to reinforce its global competitiveness in clinical research as the new government sets an ambitious course for pharma progress.